Introduction to the HESI DART Drugs in Semen Consortium
Reprod Toxicol
.
2014 Sep:48:113-4.
doi: 10.1016/j.reprotox.2014.04.007.
Epub 2014 May 4.
Authors
Connie L Chen
1
,
Bruce K Beyer
2
,
William J Breslin
3
,
Anthony M DeLise
4
,
Julia Y Hui
5
,
Graeme J Moffat
6
,
Kary E Thompson
7
Affiliations
1
ILSI - Health and Environmental Sciences Institute, Washington, DC, United States. Electronic address: cchen@hesiglobal.org.
2
Sanofi U.S., Inc., Bridgewater, NJ, United States.
3
Lilly Research Laboratories, Indianapolis, IN, United States.
4
Novartis Pharmaceutical Corporation, East Hanover, NJ, United States.
5
Celgene Corporation, Summit, NJ, United States.
6
Amgen, Inc., Seattle, WA, United States.
7
Bristol-Myers Squibb, New Brunswick, NJ, United States.
PMID:
24803405
DOI:
10.1016/j.reprotox.2014.04.007
No abstract available
MeSH terms
Animals
Female
Humans
Male
Maternal Exposure*
Pharmaceutical Preparations / metabolism*
Pregnancy
Semen / metabolism*
Toxicity Tests / methods
Substances
Pharmaceutical Preparations